发明名称 |
VEGF antagonist compositions and uses thereof |
摘要 |
The invention provides compositions and methods for treating a disease or disorder associated with vascular endothelial growth factor (VEGF). Specifically, the invention relates to an oligomerized VEGF binding domain to provide VEGF antagonism, and thereby treat diseases associated thereof. |
申请公布号 |
US9441029(B2) |
申请公布日期 |
2016.09.13 |
申请号 |
US201113814182 |
申请日期 |
2011.08.05 |
申请人 |
Genzyme Corporation |
发明人 |
Stefano James;Pan Clark;Qiu Huawei;O'Callaghan Michael;Matthews Gloria |
分类号 |
A61K38/00;C07K14/435;C07K14/71;C12N9/12 |
主分类号 |
A61K38/00 |
代理机构 |
Robins Law Group |
代理人 |
Robins Roberta L.;Robins Law Group |
主权项 |
1. A vascular endothelial growth factor (VEGF) antagonist oligomer comprising: a plurality of monomers operably linked to each other, wherein each monomer comprises the second VEGF binding domain (D2) of FMS-like tyrosine kinase-1 (FLT-1), and wherein the plurality of monomers are linked to each other through a non-protein polymer. |
地址 |
Cambridge MA US |